Trial NCT04187872

View at ClinicalTrials.gov 
Org. Study IDs: IRB201902411
Secondary IDs: OCR26353

Last trial update was posted on 2023-12-27

MeSH Interventions

Pembrolizumab

MeSH Conditions

Brain Neoplasms Carcinoma Carcinoma, Merkel Cell Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Lymphoma Microsatellite Instability Neoplasm Metastasis Neoplasms, Squamous Cell Small Cell Lung Carcinoma

Other Conditions

Brain Metastases, Adult Cervical Cancer Classical Hodgkin Lymphoma Esophageal Cancer Gastric Cancer Head and Neck Squamous Cell Cancer Hepatocellular Carcinoma Melanoma Merkel Cell Carcinoma Microsatellite Instability-High Cancer Non-small Cell Lung Carcinoma (NSCLC) Primary Mediastinal Large B-Cell Lymphoma Renal Cell Carcinoma (RCC) Small-cell Lung Cancer Urothelial Carcinoma

Stopping Reasons

Sponsor terminated

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID